Lilly Asia Ventures

Lilly Asia Ventures

VC investments in life sciences

Investment Fund Manager | China | Health Improvement

 

Overview

Lilly Asia Ventures (LAV) is a healthcare focused venture capital and private equity firm based in Shanghai and Hong Kong. LAV's investment strategy is industry specific but stage agnostic. Major coverage areas include biopharmaceuticals medical devices diagnostics healthcare services and health IT.

Investor Type

Legal Structure

Operating Status

Members

Investment Fund Manager Other Legal Structure Operating 11-50

Portfolio

Jun, 2016

Joint Series A Equity PRI

Just Biotherapeutics

Focused on the technology of biotherapeutics

Just is an integrated design company focused on the technology...

sector

Health Improvement
Disease Specific Prevention and Mitigation
Capacity Building

regions

United States of America

People

James N. Thomas


Investors / Funders


Team


Funds


Impact

Social Objectives:

Environmental Objectives:


Operational Impact:


Impact Reports & Metrics


Offices

Headquarters :

Room 2909 3 Corporate Avenue
No.168 Hubin Road
Shanghai
China



Explore

Revision History

Last Update: Oct 06, 2017 9:31 a.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2019 IMPACTSPACE. ALL RIGHTS RESERVED.